Latest Strategy Changes News

Anagenics Limited reports a significant turnaround with profitable trading in the second quarter of FY26, driven by strong brand performance and a successful capital raise. The company is poised for growth with expanding product lines and international ambitions.

Far East Gold’s December quarter report highlights significant high-grade gold discoveries at its Idenburg Project and a key regulatory approval that paves the way for accelerated development.

Janus Electric has inked a strategic partnership with a Canadian consortium to deploy swappable battery electric trucks powered by innovative negative-carbon energy, aiming to revolutionise long-haul freight electrification.

Wellnex Life reports a significant turnaround with a 31.5% revenue increase and near break-even operating cash flow in the December quarter, driven by strategic brand consolidation and cost discipline.

Aeris Resources delivered steady copper and gold output in Q2 FY26, achieving a debt-free balance sheet and a robust cash position. Exploration drilling at Tritton signals promising resource extensions.

Mesoblast Limited reported a 60% jump in Ryoncil sales to US$35 million for the December quarter, alongside securing a US$125 million credit facility that enhances its financial flexibility and supports ongoing clinical development.

Liontown Limited has successfully transitioned to 100% underground mining at Kathleen Valley, delivering a 37% increase in underground production and a 91% jump in quarterly revenue. The company is on track to reduce costs and boost recoveries as it targets a steady-state underground run-rate.

Elixinol Wellness Ltd reported a 9.5% revenue increase in Q4 FY25 alongside a 30% cut in operating costs, achieving its first underlying operating cash flow positive quarter. The company’s strategic acquisitions and e-commerce growth underpin a clear path to profitability.

Syntara Limited has made significant strides in its clinical pipeline, launching new trials and receiving key regulatory designations, positioning 2026 as a pivotal year for the company.

Aerometrex Limited has reported record first half revenue and EBITDA for the six months ending December 2025, driven by strong MetroMap subscription growth and a rebound in LiDAR sales.

Starpharma reports strong progress in strategic collaborations and internal drug development, alongside a 70% surge in Viraleze™ online sales and a solid $18.2 million cash position.

Aeris Resources delivered solid Q2 FY26 results with copper equivalent production of 10.1kt at competitive costs, strengthened its balance sheet by repaying debt, and reported promising exploration outcomes that could underpin future growth.